Published in J Med Ethics on November 21, 2010
Bullying Borrelia: when the culture of science is under attack. Trans Am Clin Climatol Assoc (2012) 0.84
Bill C-442: Shining the limelight on the Lyme-like? Can J Infect Dis Med Microbiol (2014) 0.75
Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med (2010) 13.57
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA (2008) 5.01
Lyme borreliosis. Lancet (2011) 4.81
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis (2003) 4.28
Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 3.96
Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg Infect Dis (2005) 3.90
Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med (2012) 3.79
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75
Gene sequence-based criteria for identification of new rickettsia isolates and description of Rickettsia heilongjiangensis sp. nov. J Clin Microbiol (2003) 3.59
Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2013) 3.54
Fecal microbiota transplantation: a practical update for the infectious disease specialist. Clin Infect Dis (2013) 3.32
Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep (2006) 3.32
Subjective symptoms after treatment of early Lyme disease. Am J Med (2010) 3.22
Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis (2003) 3.18
Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions. Clin Infect Dis (2005) 3.04
Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis (2011) 2.88
Correlates of axial gout: a cross-sectional study. J Rheumatol (2012) 2.86
Common misconceptions about Lyme disease. Am J Med (2013) 2.84
Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis (2007) 2.82
Prolonged Lyme disease treatment: enough is enough. Neurology (2007) 2.80
Treatment trials for post-Lyme disease symptoms revisited. Am J Med (2013) 2.75
MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. Proc Natl Acad Sci U S A (2008) 2.67
Understanding why rheumatoid arthritis patient treatment preferences differ by race. Arthritis Rheum (2009) 2.66
Novel evidence-based systemic lupus erythematosus responder index. Arthritis Rheum (2009) 2.58
Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun (2010) 2.50
Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis (2008) 2.26
Southern Tick-Associated Rash Illness (STARI) in the North: STARI following a tick bite in Long Island, New York. Clin Infect Dis (2011) 2.19
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther (2008) 2.15
The value of an infectious diseases specialist. Clin Infect Dis (2003) 2.12
Human Borrelia miyamotoi infection in the United States. N Engl J Med (2013) 2.11
Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis (2002) 1.97
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum (2002) 1.91
Anaplasma phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins. Cell Microbiol (2004) 1.87
Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol (2003) 1.82
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg (2008) 1.82
Reinfection in patients with Lyme disease. Clin Infect Dis (2007) 1.81
Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials. Arthritis Rheum (2008) 1.80
Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother (2010) 1.75
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus. J Rheumatol (2013) 1.72
Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis (2008) 1.71
Serologic markers of Lyme disease in children with autism. JAMA (2013) 1.67
Gout in the axial skeleton. J Rheumatol (2009) 1.62
Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med (2003) 1.62
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. Arthritis Rheum (2002) 1.62
Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells. J Immunol (2008) 1.61
Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study. Vector Borne Zoonotic Dis (2013) 1.59
Distinct host species correlate with Anaplasma phagocytophilum ankA gene clusters. J Clin Microbiol (2010) 1.52
Silencing of host cell CYBB gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect Immun (2009) 1.51
Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med (2012) 1.50
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis (2012) 1.49
Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann N Y Acad Sci (2006) 1.48
Validation of self-report of rheumatoid arthritis and systemic lupus erythematosus: The Women's Health Initiative. J Rheumatol (2008) 1.47
Can ventilation-feedback training augment exercise tolerance in patients with chronic obstructive pulmonary disease? Am J Respir Crit Care Med (2008) 1.46
Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes. J Clin Microbiol (2005) 1.46
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis (2012) 1.45
Neorickettsia helminthoeca and salmon poisoning disease: a review. Vet J (2009) 1.45
Single-dose prophylaxis against Lyme disease. Lancet Infect Dis (2007) 1.45
Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol (2002) 1.45
Why has Borrelia burgdorferi not been transmitted by blood transfusion? Transfusion (2013) 1.42
Poly-ticks: Blue State versus Red State for Lyme disease. Lancet (2005) 1.42
Dispelling the chronic Lyme disease myth. Minn Med (2008) 1.40
Familial breast cancer: summary of updated NICE guidance. BMJ (2013) 1.40
Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol (2002) 1.40
Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J Bacteriol (2006) 1.34
Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Expert Rev Anti Infect Ther (2009) 1.33
Emerging and re-emerging tick-transmitted rickettsial and ehrlichial infections. Med Clin North Am (2008) 1.31
Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect Immun (2003) 1.29
Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med (2007) 1.29
Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum. PLoS Pathog (2009) 1.28
The history of epidemic typhus. Infect Dis Clin North Am (2004) 1.27
Prevalence and density-related concordance of three diagnostic tests for malaria in a region of Tanzania with hypoendemic malaria. J Clin Microbiol (2011) 1.25
Brief communication: hematogenous dissemination in early Lyme disease. Ann Intern Med (2005) 1.24